Growth potential HealthEdge targets lower middle market US healthcare businesses with revenues of 5-75 million and EBITDA of 2-15 million, presenting a sizable pipeline of growth-oriented portfolio opportunities for add-on acquisitions, strategic partnerships, or recapitalizations across supply chain services, tech-enabled services, specialty products, and healthcare services.

Active deal activity Recent investments and partnerships including Western Microsurgical and Radsource, along with leadership promotions, indicate an active execution cadence and a willingness to deploy capital into growth-stage healthcare platforms, suggesting ongoing deal flow and opportunities for co-investments or sponsorship of follow-on rounds.

Strategic value add HealthEdge emphasizes operational value through founder ownership, strategic resources, and infrastructure enhancement, signaling opportunities to pitch value creation services such as scaling operations, technology modernization, and go-to-market improvements for potential portfolio companies.

Tech-enabled focus Portfolio interests include tech-enabled services and digital health logistics, enabling outreach to firms offering remote diagnostics, teleradiology, or platform-enabled post-acute care solutions, as well as providers of remote or analytics-driven healthcare workflows.

Regional and sector exposure With a Tampa base and investments in US healthcare segments spanning supply chain, devices, and services, there is room to approach healthtech, medical device distributors, and service providers in expanding regional markets, particularly those seeking institutional capital for growth, recapitalizations, or buyouts.